Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.
Richard Richieri
Advertisement
Vice President of Manufacturing and Research and Development at Avid Biosciences, Inc.
Articles by Richard Richieri
Advertisement
Latest Updated Articles
Purification of IgM Monoclonal AntibodiesPublished: March 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
